2013
DOI: 10.1177/1099800412473820
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Update on Genetic and Autoimmune Biomarkers in Pediatric Diabetes

Abstract: The complexity of determining etiology, risk, diagnosis, and treatment for diabetes in youth is increasing with the rate of related genetic and immunologic advances. Diabetes care providers must be able to explain the complex genetic and autoimmune biomarkers used in determining the risk of diabetes, diagnosis of the disease, and identification of treatment options to patients and families.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…The onset of type I DM is usually during childhood, at an average age of 7 to 15 years; however this disease can be seen at any age [ 7 , 8 ]. It is an autoimmune disease that is correlated with both genetic and environmental factors [ 9 , 10 ]. Children with diabetes may experience delayed puberty and eventually reach a lower height than their genetic potential.…”
Section: Introductionmentioning
confidence: 99%
“…The onset of type I DM is usually during childhood, at an average age of 7 to 15 years; however this disease can be seen at any age [ 7 , 8 ]. It is an autoimmune disease that is correlated with both genetic and environmental factors [ 9 , 10 ]. Children with diabetes may experience delayed puberty and eventually reach a lower height than their genetic potential.…”
Section: Introductionmentioning
confidence: 99%